{"filing":{"accession_number":"0001178913-26-004140","cik":"0001607962","ticker":"LFWD","company_name":"Lifeward Ltd.","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-10","primary_document":"zk2635970.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1607962/000117891326004140/zk2635970.htm"},"events":[{"id":27796,"run_id":25369,"accession_number":"0001178913-26-004140","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Lifeward Ltd. announced Q2 2026 financial results (ended June 30, 2026) showing revenue of $6.6 million (16% increase), operating loss of $4.2 million, and net loss of $11.5 million per share, with detailed financial statements and management commentary on commercial execution and balance sheet strengthening.","company_name":"Lifeward Ltd.","ticker":"LFWD","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":[{"id":29474,"accession_number":"0001178913-26-004140","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces financial results including revenue of $6.6 million (16% increase), operating loss of $4.2 million, and net loss of $11.5 million per share, with detailed financial statements and management commentary on commercial execution and balance sheet strengthening. The press release is furnished as Exhibit 99.1 and contains condensed consolidated statements of operations, which is the hallmark of an earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:21:40.854105+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":27797,"run_id":25369,"accession_number":"0001178913-26-004140","anchor_item_number":"5.02","event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Three directors (Robert J. Marshall, Jr., Michael Swinford, and William Mark Sigsbee) departed effective August 13, 2026, and Chief Financial Officer Almog Adar departed effective September 30, 2026, with the CFO departure treated as a termination without cause with separation benefits.","company_name":"Lifeward Ltd.","ticker":"LFWD","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":[{"id":29475,"accession_number":"0001178913-26-004140","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The Item 5.02 disclosure centers on the departure of three directors (Robert J. Marshall, Jr., Michael Swinford, and William Mark Sigsbee) effective August 13, 2026, and the departure of Chief Financial Officer Almog Adar effective September 30, 2026. While the supplemental exhibit includes earnings results, the primary 8-K Item 5.02 content focuses on executive and board departures. The CFO departure is particularly material as it involves a named executive officer in a critical financial role, treated as a termination without cause with separation benefits.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:21:40.854105+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29474,"accession_number":"0001178913-26-004140","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces financial results including revenue of $6.6 million (16% increase), operating loss of $4.2 million, and net loss of $11.5 million per share, with detailed financial statements and management commentary on commercial execution and balance sheet strengthening. The press release is furnished as Exhibit 99.1 and contains condensed consolidated statements of operations, which is the hallmark of an earnings disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:21:40.854105+00:00","company_name":"Lifeward Ltd.","ticker":"LFWD","filing_date":"2026-08-14"},{"id":29475,"accession_number":"0001178913-26-004140","item_number":"5.02","item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The Item 5.02 disclosure centers on the departure of three directors (Robert J. Marshall, Jr., Michael Swinford, and William Mark Sigsbee) effective August 13, 2026, and the departure of Chief Financial Officer Almog Adar effective September 30, 2026. While the supplemental exhibit includes earnings results, the primary 8-K Item 5.02 content focuses on executive and board departures. The CFO departure is particularly material as it involves a named executive officer in a critical financial role, treated as a termination without cause with separation benefits.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T13:21:40.854105+00:00","company_name":"Lifeward Ltd.","ticker":"LFWD","filing_date":"2026-08-14"}]}